CN115515955A - 4-[(7-氯-2-甲氧基苯并[b][1,5]萘啶-10-基)氨基]-2,6-双(吡咯烷-1-基甲基)苯酚及其盐的结晶形式 - Google Patents

4-[(7-氯-2-甲氧基苯并[b][1,5]萘啶-10-基)氨基]-2,6-双(吡咯烷-1-基甲基)苯酚及其盐的结晶形式 Download PDF

Info

Publication number
CN115515955A
CN115515955A CN202180028991.2A CN202180028991A CN115515955A CN 115515955 A CN115515955 A CN 115515955A CN 202180028991 A CN202180028991 A CN 202180028991A CN 115515955 A CN115515955 A CN 115515955A
Authority
CN
China
Prior art keywords
powder
crystalline
ylmethyl
methoxybenzo
naphthyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180028991.2A
Other languages
English (en)
Chinese (zh)
Inventor
A·贝克
D-M·格鲁亚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of CN115515955A publication Critical patent/CN115515955A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202180028991.2A 2020-04-17 2021-04-14 4-[(7-氯-2-甲氧基苯并[b][1,5]萘啶-10-基)氨基]-2,6-双(吡咯烷-1-基甲基)苯酚及其盐的结晶形式 Pending CN115515955A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20170197 2020-04-17
EP20170197.6 2020-04-17
PCT/EP2021/059604 WO2021209477A1 (en) 2020-04-17 2021-04-14 Crystalline forms of 4-[(7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)amino]-2,6-bis(pyrrolidin-1-ylmethyl)phenol and salts thereof

Publications (1)

Publication Number Publication Date
CN115515955A true CN115515955A (zh) 2022-12-23

Family

ID=70333787

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180028991.2A Pending CN115515955A (zh) 2020-04-17 2021-04-14 4-[(7-氯-2-甲氧基苯并[b][1,5]萘啶-10-基)氨基]-2,6-双(吡咯烷-1-基甲基)苯酚及其盐的结晶形式

Country Status (8)

Country Link
US (1) US20230295156A1 (cg-RX-API-DMAC7.html)
EP (1) EP4136087A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023522023A (cg-RX-API-DMAC7.html)
CN (1) CN115515955A (cg-RX-API-DMAC7.html)
BR (1) BR112022018436A2 (cg-RX-API-DMAC7.html)
CA (1) CA3175552A1 (cg-RX-API-DMAC7.html)
PH (1) PH12022552366A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021209477A1 (cg-RX-API-DMAC7.html)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101544638A (zh) * 2009-05-12 2009-09-30 重庆通天药业有限公司 乳酸咯萘啶及其药物组合物
KR20090114029A (ko) * 2008-04-29 2009-11-03 강민석 피로나리딘의 제조방법 및 이를 위한 중간체
CN103373995A (zh) * 2012-04-28 2013-10-30 上海迪赛诺药业有限公司 一种制备咯萘啶的方法
CN105461713A (zh) * 2014-09-25 2016-04-06 刘力 苯并萘啶类的新化合物及其组合物和用途
CN109843876A (zh) * 2016-10-13 2019-06-04 Mmv疟疾药物投资公司 新的抗疟剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9994577B2 (en) * 2014-07-04 2018-06-12 Merck Patent Gmbh Azepanyl-derivatives and pharmaceutical compositions comprising the same with antiparasitic activity
MX2020009711A (es) * 2018-04-11 2020-10-07 Merck Patent Gmbh Combinacion de quinolin-4-carboxamidas y derivados de benzonaftiridina como combinacion de farmacos antipaludicos.
CN112209926A (zh) * 2019-07-12 2021-01-12 中国中医科学院中药研究所 磷酸咯萘啶的多晶型物及其制备方法、应用
CN116507331A (zh) * 2020-06-15 2023-07-28 默克专利有限公司 Tlr7/8拮抗剂及其用途

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090114029A (ko) * 2008-04-29 2009-11-03 강민석 피로나리딘의 제조방법 및 이를 위한 중간체
CN101544638A (zh) * 2009-05-12 2009-09-30 重庆通天药业有限公司 乳酸咯萘啶及其药物组合物
CN103373995A (zh) * 2012-04-28 2013-10-30 上海迪赛诺药业有限公司 一种制备咯萘啶的方法
CN105461713A (zh) * 2014-09-25 2016-04-06 刘力 苯并萘啶类的新化合物及其组合物和用途
CN109843876A (zh) * 2016-10-13 2019-06-04 Mmv疟疾药物投资公司 新的抗疟剂

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
郑贤育等: "抗疟新药咯萘啶及其类似物的合成", 药学学报, vol. 17, no. 2, 28 February 1982 (1982-02-28), pages 123 *

Also Published As

Publication number Publication date
BR112022018436A2 (pt) 2022-11-01
WO2021209477A1 (en) 2021-10-21
US20230295156A1 (en) 2023-09-21
EP4136087A1 (en) 2023-02-22
JP2023522023A (ja) 2023-05-26
CA3175552A1 (en) 2021-10-21
PH12022552366A1 (en) 2024-03-18

Similar Documents

Publication Publication Date Title
JP7710223B2 (ja) 置換ピロロトリアジン系化合物およびその医薬組成物並びにそれらの使用
EA020390B1 (ru) Бензодиазепиновый ингибитор бромодомена
CN115403626A (zh) 新结晶形式
WO2019201297A1 (zh) 作为rho激酶抑制剂的苯并吡唑类化合物
JP2017061578A (ja) 有機化合物
KR102967623B1 (ko) 액티빈 수용체 유사 키나아제 저해제의 염 및 결정 형태
US20140274914A1 (en) Ach-0142684 sodium salt polymorph, composition including the same, and method of manufacture thereof
JP7843116B2 (ja) 2-(5-(4-(2-モルホリノエトキシ)フェニル)ピリジン-2-イル)-n-ベンジルアセトアミドの固体形態
CN108929329B (zh) 2-氮杂环-5-三氟甲基-8-硝基苯并(硫代)吡喃-4-酮类化合物
WO2022206937A1 (zh) 一种吡唑取代的烟酰胺类化合物的盐酸盐新晶型及其制备方法
CN102190644B (zh) 手性3-羟基吡啶-4-酮类衍生物及其合成和用途
CN113559102B (zh) 包括trh类似物和丙基辛酸的组合的组合物和丙基辛酸的药学上可接受的盐
US20230295156A1 (en) Crystalline forms of 4-[(7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)amino]-2,6-bis(pyrrolidin-1-ylmethyl)phenol and salts thereof
CN120344512A (zh) 氧异吲哚-5-甲酰胺类化合物或其盐、溶剂合物的结晶形式或无定形形式
CN118574823A (zh) Arv-110的晶型及其制备方法和用途
CN113227069B (zh) 一种化合物的晶型、其组合物及使用方法
ES2970232T3 (es) Modificaciones cristalinas de clorhidrato de N-(4,5-bismetansulfonil-2-metilbenzoil)guanidina y sales de N-(4,5-bismetansulfonil-2-metilbenzoil)guanidina
WO2016206097A1 (zh) 新的5型磷酸二酯酶抑制剂及其应用
CN115707702A (zh) Rad51抑制剂化合物的晶型及其应用
HK40115548A (en) Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-benzylacetamide
CN121079430A (zh) 唾液酸衍生物的结晶形式及其使用方法
CN106279164A (zh) 新的5型磷酸二酯酶抑制剂及其应用
WO2023006057A1 (zh) 氨基吡唑并嘧啶化合物的晶体
WO2025131047A1 (zh) 一种烟酸酯类化合物的晶型及其制备方法和应用
HK40108981A (en) Solid forms of salts of 4-[5-[(3s)-3-aminopyrrolidine-1-carbonyl]-2-[2-fluoro-4-(2-hydroxy-2-ethylpropyl)phenyl]phenyl]-2-fluoro-benzonitrile

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20221223

RJ01 Rejection of invention patent application after publication